IMA
NASDAQ
$5.73
Ikena Oncology Inc (IMA)
ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases. The company is headquartered in San Diego, California.
Sector:
Healthcare
Industry:
Biotechnology
Target: $24 (+318.85%)
Market Cap
$67M
P/B Ratio
0.54
Free Cash Flow Yield
-77.17%
Beta (5Y)
0.58
Price Chart
Valuation
Market Cap$67M
P/S83.32
P/B0.54
Profitability
Gross Profit (TTM)$800K
EBITDA-$54M
EPS-$7.25
Financial Health
Free Cash Flow Yield-77.17%
Growth & Risk
FCF 5Y CAGR+4.10%
Beta (5Y)0.58
Sharpe Ratio-0.96